Francesca Benedetta Pizzini
Overview
Explore the profile of Francesca Benedetta Pizzini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mete M, Romano L, Beltramello A, Pizzini F, Pertile G
BMC Ophthalmol
. 2024 Aug;
24(1):374.
PMID: 39187820
Background: Ocular siderosis (OS) is a significant cause of visual loss due to retained ferrous intraocular foreign bodies (IOFB). Despite its rarity, OS can lead to severe visual impairment if...
2.
Ziccardi S, Tamanti A, Ruggieri C, Guandalini M, Marastoni D, Camera V, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Aug;
11(6):e200301.
PMID: 39178066
Background And Objectives: Cognitive impairment (CI) in multiple sclerosis (MS) is frequent and determined by a complex interplay between inflammatory and neurodegenerative processes. We aimed to investigate whether CSF parvalbumin...
3.
Cecchini M, Pizzini F, Boschi F, Marcon A, Moro L, Gordon E, et al.
Neurol Sci
. 2024 Mar;
45(6):2409-2418.
PMID: 38441790
A preserved sense of smell and taste allows us to understand many environmental "messages" and results in meaningfully improvements to quality of life. With the COVID-19 pandemic, it became clear...
4.
Marastoni D, Foschi M, Eccher C, Crescenzo F, Mazziotti V, Tamanti A, et al.
Front Immunol
. 2024 Feb;
15:1343892.
PMID: 38404586
Background: Cladribine has been introduced as a high-efficacy drug for treating relapsing-remitting multiple sclerosis (RRMS). Initial cohort studies showed early disease activity in the first year after drug initiation. Biomarkers...
5.
Pizzini F, Boscolo Galazzo I, Natale V, Ribaldi F, Scheffler M, Caranci F, et al.
Radiol Med
. 2024 Feb;
129(3):467-477.
PMID: 38329703
Purpose: Arterial spin labeling (ASL) represents a noninvasive perfusion biomarker, and, in the study of nonvascular disease, the use of the single-timepoint ASL technique is recommended. However, the obtained cerebral...
6.
Ziccardi S, Pizzini F, Guandalini M, Tamanti A, Cristofori C, Calabrese M
Bioengineering (Basel)
. 2023 Jan;
10(1).
PMID: 36671613
In multiple sclerosis (MS), the transition from relapsing-remitting to the secondary-progressive phase is characterized by a progression independent of relapse activity (PIRA), resulting in physical disability accumulation and invisible symptoms,...
7.
Bosello F, Marastoni D, Pizzini F, Zaffalon C, Zuliani A, Turri G, et al.
J Neuroimmunol
. 2023 Jan;
375:578011.
PMID: 36621074
Post-infectious immune-mediated neurological complications of Sars-Cov-2 have been increasingly recognized since the novel pandemic emerged. We describe the case of a 74 years-old patient who developed a Myelin Oligodendrocyte Glycoprotein...
8.
Pini L, de Lange S, Pizzini F, Boscolo Galazzo I, Manenti R, Cotelli M, et al.
Alzheimers Res Ther
. 2022 Dec;
14(1):199.
PMID: 36581943
Background: Alzheimer's disease (AD) and frontotemporal dementia (FTD) show network dysfunctions linked with cognitive deficits. Within this framework, network abnormalities between AD and FTD show both convergent and divergent patterns....
9.
Barbi C, Pizzini F, Tamburin S, Martini A, Pedrinolla A, Laginestra F, et al.
Neurol Int
. 2022 Jun;
14(2):506-535.
PMID: 35736623
Fatigue is one of the most disabling symptoms of multiple sclerosis (MS); it influences patients' quality of life. The etiology of fatigue is complex, and its pathogenesis is still unclear...
10.
Pini L, Pizzini F, Boscolo-Galazzo I, Ferrari C, Galluzzi S, Cotelli M, et al.
Neurobiol Aging
. 2021 Dec;
111:24-34.
PMID: 34942516
The default mode (DMN) and the salience (SN) networks show functional hypo-connectivity in Alzheimer's disease (AD) and the behavioral variant of frontotemporal dementia (bvFTD), respectively, along with patterns of hyper-connectivity....